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Summary 
An important function of membrane immunoglobulin (mlg), the B cell antigen receptor, is to 
endocytose limiting quantities of antigen for efficient presentation to class II-restricted T cells. 
We have used a panel of mlg mutants to analyze the mechanisms of mlg-mediated antigen pre- 
sentation, and specifically to explore the ability of mlg to target internalized antigen to intracel- 
lular processing compartments. Transfected mlgs carrying substitutions for the transmembrane 
Tyrs87 residue fail to efficiently present specifically bound antigen. However, these mutants in- 
ternalize antigen normally, and their defect cannot be attributed to a lack of mlg-associated Igot/Ig/3 
molecules. A novel functional assay for detecting antigenic peptides in subceUular fractions shows 
that wild-type mlg transfectants generate class II-peptide complexes intracellularly, whereas only 
free antigenic peptides are detectable in the mutant mlg transfectants. Furthermore, an antigen 
competition assay reveals that antigen internalized by the mutant mlgs fails to enter the intracel- 
lular processing compartment accessed by wild-type mlg. Therefore, mlg specifically targets bound 
and endocytosed antigen to the intracellular compartment where processed peptides associate 
with class II molecules, and the transmembrane Tyr5s7 residue plays an obligatory role in this 
process.  Targeting of internalized antigen may be mediated by receptor-associated chaperones, 
and may be a general mechanism for optimizing the presentation of specifically bound and en- 
docytosed antigens in B lymphocytes and other antigen-presenting cells. 
PCs  such as macrophages,  dendritic cells,  and B  cells 
actively take up extracellular proteins for processing by 
a number of nonspecific and specific receptor-mediated path- 
ways. As opposed to macrophages, B cells have relatively slow 
rates of fluid-phase pinocytosis.  Instead, membrane Ig (mlg)  1 
on the surface of mature B lymphocytes binds  specific an- 
tigen and efficiently internalizes it for subsequent processing 
into peptides and association with class II MHC molecules 
(1-4). The intracellular compartment where processing and 
class II association occur appears similar to, but distinct from, 
early endosomes or lysosomes (5-7). Depending on the cell 
line and assay, this compartment may (6) or may not (7) con- 
tain transferrin receptors, which is interesting in light of work 
showing that targeting antigens to early endosomes by con- 
jugation to transferrin does not always promote efficient pro- 
Abbreviations used in this paper: CIIV, class II-containing  vesicles;  GAH#, 
goat anti-human/z; GAM"/2a, goat anti-mouse  "y2a;  GGG, goat gamma 
globulin; mlg, membrane  Ig; OVA, ovalbumin; PC, phosphorylcholine; 
RAMG, rabbit anti-mouse  Ig; RGG, rabbit gamma globulin; TM: Y/F, 
transmembrane  mutant, try to phe; TM: YS/VV, transmembrane  mutant, 
tyr-ser to val-val; t-OVA, tryptic fragments of OVA. 
cessing and presentation (8, 9). After internalization of an- 
tigen-mlg complexes, mlg recycles back to the cell surface. 
where it can bind additional antigen (10, 11). 
The remarkable efficiency with which mlg targets antigens 
for processing was originally attributed to the role of mlg 
as a high affinity receptor. It is, however, possible  that mlg 
may also direct the intracellular traffic of internalized antigen. 
The structural basis of such regulated trafficking is not known. 
Cytoplasmic tail motifs that mediate internalization of a va- 
riety of plasma membrane receptors have been identified. These 
motifs typically contain tyrosines or phenylalanines, as well 
as a variable number of other polar residues (12-14),  which 
are critical for efficient internalization, perhaps by mediating 
attachment to clathrin,  adaptins,  or other cytoskeletal ele- 
ments. However, these motifs do not appear to be involved 
in targeting at least  some internalized receptors to specific 
intracellular sites (15). Furthermore, the cytoplasmic tails of 
mlgM and mlgD lack any identifiable internalization motifs. 
An alternative possibility is that mlg-associated proteins, such 
as Igc~ and Ig/3, function to control the internalization and 
intracellular trafficking of mlg and mlg-bound ligands (16). 
Elucidating the structural basis of mlg-mediated antigen 
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tant for understanding how antigen is targeted to class II-rich 
vesicles in B lymphocytes (6, 7, 17). The same mechanisms 
may also be operative in other APCs that internalize antigens 
via specific receptors for class II-associated presentation. We 
have used a mutational approach ofmlg to address this ques- 
tion, using a panel of murine B lymphoma cell lines trans- 
fected with wild-type or mutant forms of a phosphorylcho- 
line (PC)-specific human IgM (18). Three of the mutants we 
analyzed showed markedly reduced abilities to present PC- 
conjugated proteins to protein antigen-specific T cells. One 
mutant lacks the three-amino acid cytoplasmic tail (Lys-Val- 
Lys) of the/~ heavy chain, and it is expressed as a phospha- 
tidylinositol-linked protein that is internalized very slowly 
(19). More interesting are two constructs in which a trans- 
membrane tyrosine residue, TyrssT, is mutated, either with 
the adjacent serine to valines  (denoted TM: YS/VV), or in- 
dividually to phenylalanine (TM: Y/F). Both these mutants 
bind and internalize antigen, but they fail to efficiently  present 
it to class II-restricted T  cells (18,  19). Moreover, the TM: 
YS/VV mutant does not associate  with Igc~ and Ig3,  and 
it fails to transduce intracellular signals upon antigen binding; 
conversely, the TM: Y/F mutant associates with Igo~ and Ig3, 
and it is competent at signaling (20, 21). Other workers have 
generated similar mutations of  murine # heavy chain and trans- 
membrane regions (22, 23), but these have not been analyzed 
for their effect on antigen presentation. Chimeric mIgs with 
the human TM: YS/VV mutations and either Igoe or Ig3 
cytoplasmic tails have also been constructed; these show normal 
intracellular signaling upon antigen ligation (20), but have 
not been previously examined for their ability to mediate an- 
tigen presentation. Thus, we have available a panel of human 
mIg mutants that provides an opportunity for analyzing the 
structural constraints on antigen internalization and processing, 
as well as the role of the mIg-associated proteins, Igc~ and 
Ig3,  in these processes. 
Materials  and Methods 
Cell Lines.  A20 murine B lymphoma cells (3~2a  +, K  +, H-2  d) 
were transfected with PC-specific  human # heavy chain constructs; 
high expressing cells were separated by cell sorting and cloned by 
limiting dilution, as described  previously (18). Cell lines were main- 
tained  in  RPMI  1640 medium  supplemented  with  10%  FCS 
(GIBCO Laboratories, Grand Island, NY), 50 U/ml penicillin, 50 
/~g/ml streptomycin, 2 mM r-glutamine,  50/~M 2-ME, and 0.6 
mg/ml G418 (GIBCO) in a 37~  humidified, 5% COs environ- 
ment. Chimeric proteins containing Igc~ or Ig3 linked to the TM: 
YS/VV mutant were expressed in A20 cells as described (20). The 
I-Ad-expressing M12.4.1 cell line and its class II- variant, M12.C.3 
(24), were generous gifts of Dr. Laurie Glimcher (Harvard School 
of Public Health, Boston, MA). DO.11, a T cell hybridoma specific 
for ovalbumin (OVA) peptide fragment OVA323-339 in the context 
of I-A  d (25), and D1.1, a T cell clone specific  for processed rabbit 
Ig (RGG) in the context of bA  d (26), were maintained and used 
as described previously (18). 
Antibodies.  F(ab')2-fragrnents  of rabbit anti-mouse Ig (RAMG) 
and RGG were obtained from Cappel (Organon Teknika, Durham, 
NC), and intact RGG and goat gamma globulin (GGG) were ob- 
tained from Sigma Chemical Co. (St. Louis, MO). M5/114, a rat 
mAb specific for I-Ab~.q/I-E  d.k used as the supernatant of the hy- 
bridoma, was obtained from American Type Culture Collection 
(Rockville, MD). Goat anti-human/~ (GAH/~), goat anti-mouse 
IgG2a (GAM~2a),  and horseradish peroxidase-conjugated  goat 
anti-rat Ig were obtained from Southern Biotechnology Associates 
(Birmingham,  AL). 
Preparation of PC-conjugated and Radioiodinated Proteins.  OVA 
(Sigma Chemical Co.) and F(ab')2-RGG  were conjugated with PC 
using the protocol described previously (18). nsI-PC-F(ab')2-RGG 
was prepared using Iodo-Beads (Pierce Chemical Co., Rockford, 
IL), with 2 ml of PC-F(ab')2-RGG at 2 mg/ml in PBS and 500 
/~Ci of 12SI-KI (Amersham Corp., Arlington Heights,  IL) for 15 
min at 25~  After removing the beads, free KI was removed by 
passing the material over a Sephadex  G50-80 column (Sigma Chem- 
ical Co.; molecular weight exclusion =  30,000) preequilibrated 
with 5 mg/ml RGG in PBS. Radioactive fractions were collected 
and extensively  dialyzed  against 5 mg/ml BSA in PBS. The recovery 
of  protein averaged  50%, and specific  activities  averaged  0.25 #Ci//~g 
PC-F(ab')2-RGG, of which >90% was precipitable in 10% TCA. 
Antigen Presentation Assays.  An antigen pulse protocol was used 
to study antigen presentation because this assay permits a direct 
comparison among clones for the rate of antigen uptake, intracel- 
lular processing, and subsequent surface  expression  of  peptide-class 
II complexes. Transfected A20 cell clones were incubated on ice 
for 15 min at  106/ml with 100-300 #g/ml PC-OVA. The cells 
were washed and warmed to 37~  for 0-120 min; internalization 
and processing of antigen were stopped by adding an excess of ice- 
cold medium. The cells were fixed at 2  x  106/ml in 1% parafor- 
maldehyde in PBS for 30 rain at room temperature, washed thor- 
oughly, and then 10  s cells were incubated with 10  s DO.11 cells 
in a total volume of 0.2 ml. After a 24-h incubation, the IL-2 con- 
centration  in the supernatants was measured as described (18). 
Antigen Internalization and Catabolism.  Washed  A20 clones at 
2.5  x  107/ml in 5/~g/ml RGG/PBS were incubated at 4~  for 
30 min with 10/~g/ml I~I-PC-F(ab')2-RGG. After washing twice 
in ice-cold PBS, cells were suspended to 107/ml in culture medium 
and incubated in duplicate at 37~  for varying lengths of time. 
Incubations were terminated by adding an equal volume of ice- 
cold PBS containing 0.2% sodium azide. After centrifugation, su- 
pernatants were precipitated at 4~  with TCA at a final concen- 
tration of 10%, and the radioactivity in the TCA pellet and super- 
natant material was counted. Pelleted cells were incubated in 2 ml 
150 mM NaC1, pH 1.2, at 4~  for 30 min to remove any surface- 
bound material (10), and released and residual cell-associated  radio- 
activity was counted. Results are expressed as a percentage of total 
radioactivity recovered at each time point from each of the four 
fractions (TCA-precipitable and soluble cpm in supernatants, acid- 
releasable and intracellular cpm from cells); total recovered radio- 
activity varied only 4-7% at all time points. 
Identification of Processed Antigen  in Subcellular Fractions.  The 
method is described in detail in Barnes and Mitchell (27). In brief, 
1-2  x  10  s transfected A20 cells were incubated with 100 #g/ml 
PC-OVA at 37~  for 30 min, washed, and ruptured by nitrogen 
cavitation after equilibration at 450 psi for 5 min at 4~  After 
removing nuclei (850 g for 10 min), the postnuclear supernatants 
were sterilely separated over 25.4% self-forming Percoll gradients 
for 1 h 45 min at 20,000 rpm 02-21 M/E centrifuge, JA-20 rotor; 
Beckman Instruments,  Palo Alto, CA). 22 0.8-ml fractions were 
sterilely harvested by gravity siphon. To assay for peptide-class II 
complexes, or for free peptides generated intracellularly,  Percoll  gra- 
dient fractions were sonicated, and 0.25 ml of each fraction was 
incubated with fixed and washed APC (either M12.4.1 or M12.C.3 
cells) at  106/ml for 4 h at 37~  After washing, the fixed cells 
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of 0.2 ml, and IL-2 production was assessed after 24 h. 
Characteristic enzyme distributions for plasma membrane (alka- 
line phosphodiesterase I [28]) and lysosomes (/~-hexosaminidase [29]) 
were defined in each experiment. In addition, the distribution of 
class II in subcelhlar fractions was determined by solid-phase ELISA. 
In brief, 25-50 #1 of each fraction was dried onto flexible micro- 
titer plates (Falcon MicroTest III; Becton Dickinson & Co., Moun- 
tain View, CA). The wells were then blocked with 2% BSA in 
borate-buffered saline  and extensively washed with PBS/0.01% 
Triton-X. M5/114 hybridoma supernatant was then added at 1:100 
dilution for I h at 37~  followed by extensive washing and incu- 
bation with 1:1,000 dilution of horseradish peroxidase-conjugated 
goat anti-rat Ig antibody for 1 h at 37~  After further washing, 
peroxidase activity was assessed using 2,2'-azino-d-[3-ethylbenzthia- 
zoline-6-sulfonic acid] diammonium salt (Sigma Chemical Co.) as 
a substrate. 
Competition for Antigen Presentation.  Washed A20 cell clones 
(10  s per well) were incubated with 10 #g/ml of primary antigen 
(PC-OVA, PC-RGG, or F(ab)'2-RAMG) and various concentrations 
of competing antigen (e.g., GAM72a, F(ab)'2-RAMG,  GAH#, or 
PC-OVA), or with 1 mg/ml nonspecific antigen (GGG, KGG, or 
OVA; internalized by fluid-phase pinocytosis). For PC-OVA as the 
primary antigen,  10  s DO.11  cells were added per well; for PC- 
KGG or F(ab)'rRAMG as the primary antigen,  2  x  104 DI.1 
cells were added per well, all in a total volume of 0.2 ml. There 
is no cross-reactivity of the DI.1 ceils with OVA or goat Ig, or 
DO.11  for rabbit or goat Ig (data not shown). Response of the 
T  cells was assessed by 1I.-2 secretion. 
In experiments analyzing the ability of cells to present prepro- 
cessed OVA, A20 cells were fixed at 2  x  106 cells/ml in 1% para- 
formaldehyde/PBS for 30  min  at  25~  followed by extensive 
washing with culture medium. These fixed cells were then incubated 
at  105 per well with  10-100  #g/ml  tryptic fragments  of OVA 
(t-OVA; gift from Dr. Ken Rock, Dana-Farber Cancer Institute, 
Boston, MA) and DO.11  cells at 10  s cells per ml; IL-2 secretion 
was assessed as described above. 
Results 
Antigen Presentation via Transfected mlg.  We have previ- 
ously shown that the cytoplasmic tailless mutant,  Cyto:A, 
and  mutants  with  substitutions  for  Tyrss7,  namely  TM: 
YS/VV and TM: Y/F, all fail to efficiently present specifically 
internalized antigen ([18]; summarized in Fig.  1). The TM: 
Y/F mutant  is particularly interesting because it associates 
with Igc~ and IgB, and it produces normal calcium and phos- 
phorylation signals upon cross-linking ([21]; and Nussenzweig, 
M.  C.,  unpublished  data).  The inability of this mutant  to 
present antigen suggests that the Igor and Ig3 mlg-associated 
proteins are not sufficient for presentation of antigens inter- 
nalized by mlg. To further examine this, we assayed the an- 
tigen presenting ability of the TM: YS/VV mutant to which 
either Igor or Ig3 cytoplasmic domains were fused to generate 
chimeric molecules. Under conditions in which the bulk of 
the antigen is taken up by receptor-mediated endocytosis, A20 
cells  expressing  the  chimeric  Ig  molecules  also  failed  to 
efficiently present PC-OVA to OVA-specific T  cells (Fig.  2 
A). All the transfected cells showed comparable levels of IL-2 
induction after a 24-h incubation with PC-OVA (Fig. 2 B) 
or nonhaptenated OVA (not shown) because during this in- 
terval, significant amounts of antigen are internalized by fluid- 
phase pinocytosis. Therefore, even the transfectants that fail 
to present antigen internalized by mlg have the capacity to 
pinocytose, process, and present the same protein antigen to 
specific T cells. By flow cytometry, all these clones exhibited 
comparable surface expression of transfected mlg ([18, 20]; 
data not shown),  indicating that the inability to efficiently 
present  antigen  is  not  attributable  to  diminished  antigen 
receptor expression. Since fusing the cytoplasmic tails of ei- 
ther Igoe or Ig3 to the TM: YS/W  mutant restores its ability 
to transduce signals (20), we conclude that Igor and/or Ig3 
Transmembrane  domain  Cytoplasmic  lntracellular  Igct/Igl5  Antigen 
Domain  Signalling  Association  Presentation 
I  I  I 
wild-type  N  L  W A  T A  S  T  F  I V  L  F  L  L  S  L g  Y $  T  T  V  T L  F  X V  K-COOH  +  ~"  + 
Cyto:  &  ..........................  COOH 
TM:  YS/VV  ..................  V  v  .........  COOH 
rM:  Y/F  ..................  *  ..........  coos  +  + 
YS/VV-Ig~  ..................  V  V  ......  Ig~  181--228  + 
YS/VV.Igct 
Y_  ..................  v  v  ......  ,gOt 160-220 
I  I  I 
569  587  597 
+ 
Figure  1.  Sequences  and functions of wild-type and mutant human mlgM constructs. Amino acids are represented  by their single-letter code. Cyto, 
cytoplasmic tail; TM, transmembrane region. YS/W-Ig/~ and YS/VV-Ig~ are chimeric constructs using the extracelhlar and transmembrane domains 
from the TM: YS/VV mutant, with the indicated domains from the Ig~ and Ig~ sheath molecules, respectively.  Italicized residues in the wild-type 
sequence represent amino acids conserved  among all isotypes; the underlined residue is a threonine in the transmembrane region of murine mlg. Dashes 
indicate identity with the wild-type sequence; residues in bold face represent specifically  mutated amino acids. The numbers indicate the positions 
of the # heavy  chain amino acids. The results of functional analyses and Ig~/Ig3 associations are summarized from references  18, 20, 21, and this article. 
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Figure 2.  Antigen  presentation by the transfected  A20 
clones. (A)  A20  transfectants were pulsed with 300 
#g/ml PC-OVA for the indicated times. After washing, 
the cells were fixed and used as APCs for 10  S DO.11 
cells in triplicate. After 24-h culture, the supernatants 
were assayed for IL-2. (B) A20 transfectants were con- 
tinuously  cultured for 24 h with DO.11 and 300/zg/ml 
of PC-OVA, and supernatants  were assayed for IL-2. 
Comparable results were obtained by continuous incu- 
bation of all A20-transfectant clones with DO.11 and 
1,000/~g/ml  nonhaptenated OVA (not shown). --0-, 
Wild type;  O  ,  TM: YS/VV; -D-,  YS/VV-Ig3; 
~-,  YS/VV-Ig~. 
are required for the signaling function of mlg, but are not 
sufficient to restore efficient antigen presenting function to 
a defective mutant  mlg. 
Antigen  Internalization and  Degradation in  mlg  Transfec- 
tants.  Inefficient presentation of antigen that binds to mu- 
tant mlg molecules could result from a failure to internalize 
antigen, process it, or form complexes of processed peptides 
with class II molecules. In the next series of experiments, 
each step in this sequence was examined. The internalization 
and catabolism of antigen were analyzed by following the 
fate of t2SI-labeled PC-conjugated protein in A20 clones ex- 
pressing the various transfected PC-specific mlgs.  The an- 
tigen we chose for these experiments was  PC-conjugated 
F(ab')2 RGG because it can be readily radioiodinated and it 
A  wild-type  B  Cyto: A 
80 
801  -e--  soluble peptide 
--@-- intracellular  E  60  ~"  ~lB 
60-  ~  -u--  cell surface  E= 
o  \  \  ~  intact antigen 
"6  ~  "6 
0~  ~  0T-  7  7  .  .... 
(  1'5  30  60  120  0  15  30  60  120 
incubation time (rain)  Incubation time (rain) 
C  TM: YSNV  80  D  TM: Y/F  so,   g 
8  ..  .it 
Incubation time (min I  ￿9 (  I 
E  YSNV-Ig~  80  F  YSNV-Igc~ 
80, 
E  E  60 
'~  40  ~  40 
;  ￿9  - 
0  ,  ,  0 
1'5  3b  6b  1~0  0  ~  3b  6b  1~0 
Incubation time (mln)  incubation time (rain) 
Figure 3.  Internalization  and 
degradation  of  PC-conjugated 
123I-F(ab)'2-RGG by  transfected 
A20 clones. After binding  antigen 
and washing, cells were warmed 
for varying intervals at 37~  be- 
fore terminating internalization 
with an equal volume of ice-cold 
PBS containing 0.2% azide. Cell- 
associated radioactivity  released  by 
acid treatment is identified as cell 
surface (IB); acid-resistant cell-as- 
sociated radioactivity is denoted 
as intracellular (O); radioactivity 
in  the  supernatant  precipitable 
with 10% TCA is identified as in- 
tact  antigen (A);  TCA-soluble 
supernatant  radioactivity  is  de- 
noted  as  soluble  peptide  (A). 
Results are expressed as percentage 
of total recovered radioactivity at 
each time point (total recoveries 
being 70-90% of initially bound 
radioactivity). 
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PC-OVA) in antigen presentation assays (not shown). After 
binding PC-F(ab')z-RGG  at 4~  and washing extensively, 
cells were warmed to 37~  for varying times. Radioactivity 
in the supernatant was separated into TCA-precipitable ("in- 
tact antigen") and TCA-soluble ("soluble peptide") fractions; 
cell-associated radioactivity was separated into "cell surface" 
(released by treatment with acid) and "intracellular"  (resis- 
tant to acid). As shown in Fig. 3 A, wild-type mlg rapidly 
internalized specific antigen with maximal uptake by 15 min, 
and degraded (TCA-soluble) antigen continued to accumu- 
late in the supernatant at a steady rate over the 2-h time course. 
The rates of uptake and catabolism are very similar to those 
described previously for specific  antigen uptake by human 
B cell clones (10). By comparison, the Cyto:A mutant (Fig. 
3 B), which is anchored to the plasma membrane by a phos- 
phatidylinositol linkage (19), showed slow internalization of 
bound antigen with a correspondingly slow generation of 
TCA-soluble degraded fragments. This behavior is consistent 
with a phosphatidylinositol-anchored molecule lacking the 
appropriate transmembrane or cytoplasmic domains to signal 
efficient internalization,  and it provides an explanation for 
the inefficiency of this construct in mediating antigen pre- 
sentation.  Interestingly,  both the tyrosine transmembrane 
mutants  (TM:  YS/VV  and  TM:  Y/F,  Fig.  3,  C  and D, 
respectively), which also fail to efficiently mediate antigen 
presentation,  showed rates  of antigen  internalization  and 
catabolism that were virtually identical to the wild-type con- 
struct. Similar results were seen with chimeric mlgs containing 
the YS/VV transmembrane mutation fused to IgB (Fig. 3 
E) or Igc~ (Fig. 3 F) cytoplasmic tails. These mutants must 
therefore retain the signal for rapid ligand-induced endocy- 
tosis. Moreover, at the level of sensitivity of this assay, all 
the tyrosine transmembrane mutants directed internalized an- 
tigen into compartment(s) where comparable levels of an- 
tigen catabolism occurred. The slight apparent lag in the gener- 
ation of TCA-soluble fragments in the TM: YS/VV mutants 
(relative to wild-type or TM: Y/F mutants) was not a con- 
sistent finding. In fact, in some experiments, wild-type-trans- 
fected constructs lagged behind the TM:  YS/VV mutants 
in release of degradation products. These results indicate that 
the tyrosine-transfected mlgs, including one (TM: YS/VV) 
that fails to associate with Igc~ and Ig/3, all efficiently inter- 
nalize and mediate the degradation of bound ligand. 
Generation of Processed Peptides in A20 Transfectants.  The 
bulk degradation of protein antigens, as measured by the re- 
lease of TCA-soluble radioactivity (Fig. 3), is clearly not a 
reliable indicator of antigen processing and generation of func- 
tionally relevant peptides. Qiu et al. (17) and our group (27) 
have recently developed an assay in which B lymphoma cells 
are allowed to process an antigen, and subceUular fractions 
are subsequently assayed for the presence of peptide-MHC 
complexes capable of stimulating T  cells.  In our assay, the 
majority of the processed peptides detected from wild-type 
mlg-transfected cells are already associated with class II, since 
these peptides can be presented to T cells by fixed, class II-nega- 
tive APCs or when bound to culture wells (27). By incubating 
subcellular fractions with APCs that do or do not express 
class II in the assay, this method enables one to distinguish 
free peptides from class II-associated peptides generated in- 
tracellularly. 
To determine if wild-type and mutant (TM: YS/VV) mlg 
transfectants differed in the generation of class II-associated 
peptides, the A20 clones were pulsed with PC-OVA for 30 
min at 37~  ruptured, and fractionated on self-forming con- 
tinuous Percoll gradients, as described (27).  Fractions were 
incubated with fixed class II + M12.4.1 or class II- M12.C.3. 
cells. The pulsed APCs were washed, incubated with DO.11 
cells,  and IL-2 production was measured after 24 h. When 
PC-OVA was internalized by wild-type mlg, the subcellular 
fractions contained peptides that were presented identically 
by fixed class  II §  and class  II-  APCs (Fig. 4 A;  ref.  27). 
Therefore, antigen is processed and peptide-class II complexes 
are efficiently generated intracellularly in the wild-type trans- 
fectant.  In contrast, in the TM:  YS/VV transfectants,  the 
antigen was processed into peptides that were presented only 
by the fixed class II § APCs (Fig. 4 B). Therefore, the TM: 
YS/VV mutant not only internalizes antigen, but it delivers 
the antigen into a proteolytic compartment.  The defect is 
that the peptides fail to associate with class II molecules. Note 
also that in both wild type and mutant transfectants, most 
of the processed peptide was detected in fractions consistent 
with the low to intermediate density class II-containing vesicles 
that have been described recently (6, 7). Furthermore, in both 
cell lines, most of the class II was in low-density fractions, 
particularly  the plasma membrane,  and not in denser or- 
ganetles. This pattern of class II localization is characteristic 
of A20 and other B lymphoma cells (6,  7,  17). 
Competition for Antigen Presentation by Endogenous Versus 
Transfected mlg.  In the final set of experiments, we used a 
functional assay to ask if wild-type and mutant mlg mole- 
cules internalize and concentrate antigen in the same com- 
partment in intact cells. By virtue of having two distinct mlgs 
on their surface, transfected A20 cells may specifically inter- 
nalize ligands bound to either the endogenous murine IgG2a 
(antigen specificity unknown) or to the transfected PC-specific 
human IgM construct. We found that antigens internalized 
by one wild-type mlg reduced the concurrent presentation 
of antigens internalized by the other. 
Thus, in wild-type cells, presentation of antigen specifically 
internalized by the transfected wild-type mlg (e.g., PC-OVA 
or PC-RGG)  was  inhibited  m65%  by coincubation with 
F(ab')2-RAMG  or GAM'y2a (Table 1). Similarly, presenta- 
tion of ligands internalized via the endogenous mlg was in- 
hibited by antigens internalized via the transfected wild-type 
mlg (see below). Competition was seen only for antigen in- 
ternalized specifically in association with mlg; even a 10-fold 
excess of antigen internalized by nonspecific fluid-phase pinocy- 
tosis (e.g.,  GGG or RGG)  did not effectively compete for 
antigen presentation (Table 1). The implication is that there 
is some limiting step in the sequence of antigen internaliza- 
tion/targeting/processing/class II association/surface reexpres- 
sion.  When  two  antigens  are  spedfically targeted  to  the 
appropriate intraceUular processing compartment by inter- 
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Figure 4.  Identification of processed peptides and peptide-class II complexes in A20 transfectants. Wild-type (A) or TM: YS/VV (B) transfectants 
were incubated with 100 #g/ml of PC-OVA for 30 rain at 37~  ruptured by nitrogen cavitation,  and fractionated on Percoll gradients. Individual 
fractions were incubated with paraformaldehyde-fixed M12.4.1 (class II +) or M12.C.3 (class II-) B cell lines and washed. The cells were incubated 
with the DO.11 T cell hybridoma,  and IL-2 levels were assayed in 24-h supernatants (bottom panels).  Fractions were also assayed for plasma membrane 
and lysosomal markers, and for class II, as described in Materials and Methods (top panels).  Controls showed that fixed M12.4.1 cells presented t-OVA 
but not intact OVA to DO.11  (IL-2 levels of 3.5 and 0 U/ml, respectively), whereas M12.C.3 cells presented neither (IL-2 =  0 U/ml). 
nalization via two mlgs, there is competition for one or more 
steps, and a net reduction in the surface expression of the 
processed  peptide-class II complexes  detected by the responding 
T  cell. Control experiments using fluorimetry to evaluate 
receptor-mediated endocytosis showed that the rate of inter- 
nalization of one mlg was not affected by simultaneously in- 
cubating the cells with antibody to the other mlg (not shown). 
We conclude that the transfected/z and endogenous 3~2a mlgs 
internalize bound ligands independently of each other, and 
that competition for antigen processing and presentation does 
not occur at the level of internalization.  Additional controls 
showed that whereas F(ab')2-RAMG or GAMy2a inhibited 
presentation  of PC-OVA (Fig. 5 A), neither inhibited the 
presentation of preprocessed t-OVA to DO.11 T cells (Fig. 
5 B). Therefore,  antigen competition in this system is not 
due to competition for binding to a limiting number of sur- 
face class II molecules, since class II molecules are clearly avail- 
able to bind and present exogenous peptides. 
Antigenic competition is therefore another way of assessing 
whether the transfected mlgs deliver antigen to the same in- 
tracellular compartment as the endogenous (normal) mlg. 
The results of antigen competition studies were strikingly 
different with the Tyrss7 transmembrane mutants.  In wild- 
type transfected cells, presentation of F(ab')2-RAMG (inter- 
nalized via the endogenous mIg) to D1.1 cells was inhibited 
"~  by coincubation of the cells with GAH~ or PC- 
haptenated proteins, both of which are internalized via the 
transfected mIg (Fig. 6 A  and Table 2). However, in both 
the TM: YS/VV (Fig. 6 B) and TM: Y/F (Fig. 6 C) clones, 
presentation  of F(ab')2-RAMG was not inhibited  by coin- 
cubation with GAH# or PC-OVA (see  also Table 2). There- 
fore, antigens internalized by the tyrosine mutant mIgs do 
not effectively interfere with the processing and presentation 
of antigen internalized via the endogenous murine mIg, con- 
sistent with the conclusion that mutant mIg delivers antigen 
to a different intracellular  compartment. 
Discussion 
In this study, we have used a panel of cloned A20 murine 
B cell lines, transfected with various human mIg constructs, 
1710  Membrane  Ig Regulates Tra~c of Internalized  Antigen Table 1.  Antigen Internalized by Endogenous mlg Competes  for 
Processing of Antigen Internalized with Wild-type mlg 
Percentage of response 
Primary  to primary 
antigen  Competitor  antigen  alone 
PC-KGG 
PC-OVA 
GAM'y2A  33.4  _+  16.2  (4) 
GGG  124.5  _+ 32.5 (3) 
GAM3~2A  36.4  _+  21.6 (9) 
GGG  110.1  _+  13.9 (6) 
F(ab')2-KAMG  36.7  _+  12.5  (7) 
KGG  93.5  _+ 9.7 (5) 
For experiments  with PC-RGG as the primary antigen,  10  s wild-type 
transfected A20 cells were incubated in triplicate for 24 h with 2  x  104 
D1.1 cells in the presence of 5 #g/ml PC-RGG and the indicated com- 
petitors (10/zg/ml GAM'y2A or 1 mg/ml GGG). 
For experiments  with PC-OVA as the primary antigen,  10  s wild-type 
transfected  A20  cells were incubated  in  triplicate  for  24  h  with  10  s 
DO.11 cells in the presence of 30-100 #g/ml PC-OVA and the indicated 
competitors (10 #g/ml GAM3,2A,  1 mg/ml GGG,  10 #g/ml F(ab')z- 
RAMG, or 1 mg/ml RGG). 
After 24 h, supernatants  were harvested and assayed for IL-2. Results 
are expressed as the percentage  of IL-2 generated  in the absence of com- 
petitor  _+  1 SD; the numbers in parentheses  represent  the number of 
experiments. Data in boldface are statistically  significant  (p <0.01). 
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to examine the effects of mlg transmembrane structure on 
the ability of the B cell antigen receptor to efficiently mediate 
presentation of  bound antigen. The results indicate that wild- 
type mlg internalizes bound antigen into a compartment(s) 
where peptides are generated and can associate with class II 
molecules. It is likely that this represents the same low den- 
sity endocytic compartment (CIIV)  recently described by 
Amigorena et al. in A20 cells (6), and by West et al. (7) in 
a human B-lymphoblastoid cell line. In contrast, the Tyrss7 
mutants of mlg, including those that interact with the IgoJfl 
mlg-associated molecules, internalize antigen to a site where 
proteolytic degradation occurs, but peptide-class II complexes 
are not generated. This result suggests either that antigen 
processing and class II association occur in distinct intracel- 
lular compartments, or that the compartment entered by wild- 
type mlg is  capable of both activities,  and that it is  not 
efficiently accessed by the Tyrss7 mutants. Moreover, our ex- 
periments establish that the transmembrane Tyrss; is essen- 
tial to target mlg to an antigen processing compartment, and 
that neither Igor, Igfl, nor the combination of  both is sufficient 
to direct appropriate receptor trafficking. 
Our results differ significantly from those of Patel and Neu- 
berger (16), who found that association of mlg with Igfl was 
critical for efficient receptor-mediated endocytosis, and that 
portions of the cytoplasmic domain of Igfl were sufficient 
to direct mlg and bound antigen for efficient antigen pro- 
cessing and presentation. In our experiments, changes in the 
transmembrane domain were limited to YS/VV and Y/F sub- 
stitutions, whereas these investigators altered large blocks of 
Figure  5.  Competition for antigen presentation. (A) 10  s wild-type A20 
transfectants were incubated with 50 #g/ml PC-OVA alone or with PC- 
OVA plus  10 #g/ml F(ab)'z-RAMG or  10  /~g/ml  GAM3,2a,  and  10  s 
DO.11 cells; IL-2 levels were assayed from 24-h supernatants.  (B) Wild- 
type A20 transfectants  were incubated  at  106 cells/ml for 24 h at 37~ 
in  medium  alone  or  with  10  /~g/ml  F(ab)'2-RAMG  or  10  /~g/ml 
GAM3,2a. The cells were then fixed, and l0  s were incubated in triplicate 
with  l0  s DO.11  cells and the indicated  concentrations  of t-OVA; IL-2 
levels were assayed from 24-h supernatants. 
contiguous amino acids.  The more extensive substitutions 
resuhed in Igs that did not associate with Igo~/Ig~, and were 
also no longer rapidly internalized upon cross-linking. In the 
constructs we have analyzed, even in the absence of Igc~ and 
Ig/3 association, internalization of the mIg was maintained. 
This is in agreement with others who found maintenance 
of antigen internalization even after replacing the entire trans- 
membrane region with a class II transmembrane cassette (30, 
31).  The mutants described in those papers likewise failed 
to efficiently present antigen, but this was attributed to in- 
appropriate intracellular traffcking associated with increased 
rates ofreceptor-ligand recycling to the cell surface (31). Fur- 
thermore, Patel and Neuberger (16) also found that linking 
the cytoplasmic domain of Ig/~ to the mutants restored rapid 
internalization, as well as effcient antigen presentation. In 
contrast, our TM: Y/F mutant mlg associated with Igt~ and 
IgB, and it displayed normal signal transduction (18, 21), as 
well as a normal rate of internalization, yet did not mediate 
efficient antigen presentation (18). Similarly, our chimeric con- 
structs, composed of mlg with the TM: YS/VV mutation 
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Fig,,re  6.  Tyrosine transmembrane mutants do not compete for antigen 
presentation.  105 transfectants  (A, wild type;  B, TM: YS/VV;  C, TM: 
Y/F) were incubated  with 2  ￿  104 D1.1  cells and  10/~g/ml F(ab)'z- 
RAMG alone or with the same antigen plus increasing  concentrations 
of competitors that bind to the transfected mlg (GAH/x [0] or PC-OVA 
[O]), or with 1 mg/ml of competitors  that are internalized by fluid-phase 
pinocytosis (GGG [I] or OVA [A]). IL-2 levels were measured in 24-h 
supernatants  and are expressed as the percentage  of response to F(ab')2- 
RAMG alone. Maximal  response (Ib2 secretion in response  to F(ab')2- 
RAMG in the absence of competitor) was as follows: wild type, 216 U/ml; 
TM:  YS/VV,  220  U/ml;  TM:  Y/F,  25  U/ml.  Competitors:  --O--, 
GAH#; --O--, PC-OVA; --m-, GGG; ~,  OVA. 
and  Igor  or  Ig~  cytoplasmic  domains,  showed  the  same 
signaling-competent but presentation-defective phenotype. 
One way to reconcile the differences between our results 
and those of Patel and Neuberger is to postulate that an addi- 
tional receptor component is necessary for the correct intra- 
cellular targeting of internalized mlg. In this model, either 
Tyr5s7 or other transmembrane amino acids could interact 
with the as yet unidentified receptor component (see below). 
Another possibility is that extensively mutated mlg constructs 
may be expressed on the cell surface as phosphatidylinositol- 
linked molecules; such molecules will be poorly internalized, 
fail to interact with Igot/Ig~, and will not mediate efficient 
antigen presentation (19,  20, 21).  In support of this possi- 
bility, Wienands and Reth (32) have demonstrated a sponta- 
neous variant of the J558L myeloma cell line (which nor- 
mally does not exhibit surface mlg because of an absence of 
Igor) that expresses IgD on its surface as a phosphatidylinositol- 
linked molecule. The fact that efficient antigen presentation 
can be restored by appending portions of the cytoplasmic tail 
of the Ig/3  molecule to mutant mlg (16)  may then be at- 
tributable to expression of that chimeric construct as a trans- 
membrane molecule, as opposed to a phosphatidylinositol- 
linked Ig. 
From an immunologic point of view, it makes sense for 
B cells to ensure that the bulk of their class II is occupied 
by peptides derived from proteins to which they are capable 
of making antibodies. Therefore, protein antigens bound to 
the mlg should be efficiently and preferentially shuttled from 
the plasma membrane to the appropriate intraceUular site (such 
as the recently described CIIV compartment; [6]) where pro- 
cessing and class II association will occur. This intracellular 
site should also be sequestered from the normal endocytic 
pathway, although high concentrations of extracellular an- 
tigens may induce a "spillover" into the compartment. This, 
in fact, may explain why antigens targeted to various B cell 
surface molecules, including the transferrin receptor, may be 
presented more efficiently than pinocytosed proteins; binding 
to cell surface molecules may lead to high local concentra- 
tions  of antigen  (3,  8).  In  addition,  there may be  a low 
efficiency delivery of molecules from, for example, the early 
endosome to the processing compartment (6). 
The ability of mlg to preferentially target antigen to the 
intracellular-processing/class II-binding organelle(s) raises the 
issue of what molecule(s) mediate this targeting. One possi- 
bility  is  that  the  transmembrane  domain  of  mlg,  and 
specifically the transmembrane TyrssT, provides a binding site 
for an as yet unidentified chaperone-like molecule that trafficks 
to the class  II-rich processing vesicle.  If this model is cor- 
rect,  then  our  results  indicate  that  Igc~ and  Ig/~  are  not 
sufficient for correct intracellular trafficking. Alternatively, 
the  transmembrane  domain may have a  specific  sequence 
directing the retention of internalized mlg within appropriate 
intracellular organelles. It is tempting to speculate that similar 
mechanisms,  involving other  receptor molecules in other 
APCs, may play a role in efficiently delivering antigens to 
specific processing compartments. We are currently using mor- 
phologic and cell fractionation techniques (27) to directly ex- 
amine the intracellular traffic of internalized wild-type and 
mutant mlg molecules, as well as the mlg-associated pro- 
teins that may regulate this traffic.  Such mlg mutants pro- 
vide unique tools for analyzing the mechanisms of antigen 
processing, and more general issues of the structural constraints 
on patterns of receptor-mediated endocytosis and intracellular 
trafficking. 
1712  Membrane  Ig Regulates  Traffic of Internalized  Antigen Table 2.  Antigen Internalized by Tyrosine Transmembrane Mutants Does Not Compete for Processing of Antigen Internalized with 
Endogenous mlg 
Percentage of response to F(ab')2-RAMG alone 
Competitor 
A20 transfectant  GAH/z  GGG  PC-OVA  OVA 
Wild  type  33.2  _+  26.1  (10)  123.1  _+  20.6  (10)  68.0  +  19.1  (8)  94.8  _+  11.6  (4) 
TM:  YS/VV  94.9  _+  14.8  (5)  93.6  _+  21.8  (5)  92.9  _+  22.4  (10)  106.0  _+  0.8  (2) 
TM:  Y/F  82.9  _+  9.1  (4)  98.2  (1)  102.2  _+  19.5  (4)  94.3  _+  8.1  (2) 
A20 transfectants were incubated in triplicate for 24 h with 2  x  104 DI.1 cells in the presence of 10 #g/ml F(ab')z-RAMG and the indicated com- 
petitors (10 #g/ml of GAH#, 30-100 #g/ml of PC-OVA, or 1 mg/ml of GGG or OVA).  Supernatants were then harvested and assayed for IL-2. 
Results are expressed as percentage of IL-2 generated in the absence of competitor  _+  1 SD; the numbers in parentheses represent the number of 
experiments. Data in boldface are statistically significant ~  g0.05). 
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